Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicita Andreotti

Showing results (181-190 of 236) with videos related to

Pageof 24
Sort By:
Circulation. Heart Failure|January 15, 2017
Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery Disease: A Meta-AnalysisGeorg Wolff, Dimitrios Dimitroulis, Felicita Andreotti, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 26, 2011
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on ThrombosisGregory Y H Lip, Felicita Andreotti, Laurent Fauchier, et al.
Circulation|February 15, 2021
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 TrialThomas A Zelniker, Maddalena Ardissino, Felicita Andreotti, et al.
Annals of Internal Medicine|June 21, 2017
Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysisMichalina Kolodziejczak, Felicita Andreotti, Mariusz Kowalewski, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 16, 2026
Transcatheter aortic valve thrombosisMia Ravn Jacobsen, Daniël C Overduin, Rikke Sørensen, et al.
Thrombosis and Haemostasis|March 25, 2014
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novelSteen Husted, Raffaele de Caterina, Felicita Andreotti, et al.
JACC. Cardiovascular Interventions|October 30, 2024
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous InterventionsMattia Galli, Felice Gragnano, Martina Berteotti, et al.
JACC. Cardiovascular Interventions|October 17, 2024
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac InterventionsMattia Galli, Felice Gragnano, Martina Berteotti, et al.
Mayo Clinic Proceedings|March 3, 2019
Age-Related 2-Year Mortality After Transcatheter Aortic Valve Replacement: the YOUNG TAVR RegistryEliano P Navarese, Felicita Andreotti, Michalina Kołodziejczak, et al.
Nature Reviews. Cardiology|September 26, 2018
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugsGiuseppe Patti, Ilaria Cavallari, Felicita Andreotti, et al.
Pageof 24

Showing results (181-190 of 236) with videos related to

Sort By:
Pageof 24
Circulation. Heart Failure|January 15, 2017
Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery Disease: A Meta-AnalysisGeorg Wolff, Dimitrios Dimitroulis, Felicita Andreotti, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 26, 2011
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on ThrombosisGregory Y H Lip, Felicita Andreotti, Laurent Fauchier, et al.
Circulation|February 15, 2021
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 TrialThomas A Zelniker, Maddalena Ardissino, Felicita Andreotti, et al.
Annals of Internal Medicine|June 21, 2017
Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysisMichalina Kolodziejczak, Felicita Andreotti, Mariusz Kowalewski, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 16, 2026
Transcatheter aortic valve thrombosisMia Ravn Jacobsen, Daniël C Overduin, Rikke Sørensen, et al.
Thrombosis and Haemostasis|March 25, 2014
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novelSteen Husted, Raffaele de Caterina, Felicita Andreotti, et al.
JACC. Cardiovascular Interventions|October 30, 2024
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous InterventionsMattia Galli, Felice Gragnano, Martina Berteotti, et al.
JACC. Cardiovascular Interventions|October 17, 2024
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac InterventionsMattia Galli, Felice Gragnano, Martina Berteotti, et al.
Mayo Clinic Proceedings|March 3, 2019
Age-Related 2-Year Mortality After Transcatheter Aortic Valve Replacement: the YOUNG TAVR RegistryEliano P Navarese, Felicita Andreotti, Michalina Kołodziejczak, et al.
Nature Reviews. Cardiology|September 26, 2018
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugsGiuseppe Patti, Ilaria Cavallari, Felicita Andreotti, et al.
Pageof 24